Corporate Actions & Capital Structure › Sub-category
M&A / Stake Purchase / Joint Venture
4 articles
Orchid Pharma Q1 Revenue Up 16% YoY
Orchid Pharma submitted an investor presentation for Q1 FY27, reporting standalone revenue of ₹304 Cr, a 16% YoY increase.
EBITDA surged 178% to ₹25 Cr, while PAT was ₹12 Cr, a significant improvement
Minda Corporation Q1 FY27 Revenue Hits Record INR 1,846 Cr
Minda Corporation reported record Q1 FY27 revenue of INR 1,846 crore, a 33.2% YoY growth, with EBITDA at INR 212 crore and PAT surging 216% to INR 206 crore.
The company consolidated Minda VAST, addin
Speciality Restaurants FY26 Revenue Grows 9.2% to ₹476 Crore
Speciality Restaurants reported consolidated revenue growth of 9.22% to ₹476.47 crore with PAT of ₹20.72 crore after absorbing an exceptional employee-benefit charge of ₹3.34 crore.
The Board recommen
Agribio Spirits Q1 FY27 Net Profit ₹1.21 Crore
Agribio Spirits Board approved Q1 FY27 un-audited standalone and consolidated financial results for quarter ended June 30, 2026.
Standalone net profit declined 43% YoY to ₹23.75 lakhs while consolidat